Search Results 581-590 of 3737 for 搜索痕迹咨询邮箱：lgooxc@hotmail.com
Learn how you can access ResearchMatch, a free, secure national registry Mayo Clinic helped develop for people who want to volunteer for clinical research.
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · Overview · Participation eligibility.
To assess incident reporting frequency by trainees; To analyze the changes in barriers to incident reporting and the impact of the patient safety video ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this First-In-Human study is to assess the safety, tolerability, pharmacokinetics (PK), immunogenicity and preliminary ...
The primary objective of this study is to evaluate whether the combination of semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firsocostat ...
About this study. The purpose of this study is to test whether markers of cellular aging and the SASP are elevated in subjects with obesity and further ...
The purpose of this study is to identify lifestyle and health variable associated with abnormal cognitive aging and the development of Alzheimer's Disease (AD) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.